2 In sharp contrast to overall trends, the incidence of CRC appears to be increasing among adults younger than 50 years, 1,3 a group for whom average-risk screening is not routine. Particularly concerning is a trend toward advanced-stage CRCs, 1, 3 suggesting a potential role for increased clinical vigilance and more prompt evaluation of symptomatic patients. To raise clinical awareness and facilitate recognition, we undertook a cohort study to (1) examine incidence trends; (2) define the distinct clinicopathologic manifestations of young-onset CRC; and (3) identify risk factors for advanced-stage disease.
Methods. We used the National Cancer Database (NCDB), a hospital-based cancer registry sponsored by the American College of Surgeons and American Cancer society that captures 70% of all incident cancers annually. 4 We identified patients diagnosed as having in- Comment. This cohort study of young-onset CRC, the largest to date, highlights an alarming rise in incidence since 2001. Most worrisome is the high proportion of stage III/IV disease ( Figure) , consistent with a prior smaller population-based report. 6 In the absence of routine screening, contributing factors to these trends may include (1) a reluctance on the part of young adults to seek medical care 7 ; (2) the large percentage of young adults without insurance or ready access to care (18.3%-29.2% for adults aged 18-44 years vs 1.3%-13.6% for adults older than 45 years 8 ); and (3) an underappreciation of the increasing risk for young-onset CRC, leading clinicians to overlook or dismiss symptoms that are nonspecific but may be consistent with CRC (ie, rectal bleeding, abdominal pain or cramping, change in bowel pattern). Finally, the predilection of young-onset CRCs for the distal colon and rectum identify these as high-yield anatomic regions for endoscopic evaluation in symptomatic patients and as potentially cost-effective targets for screening programs in presymptomatic young adults.
This study could not establish the mechanisms underlying observed sociodemographic disparities, nor did it explore the molecular basis of young-onset CRC (familial adenomatous polyposis was excluded). Notwithstanding, these data argue for heightened awareness of these concerning trends in young-onset CRC. Symptomatic young patients should undergo timely sigmoidoscopy at a minimum, if not a full colonoscopy. Identifying high-risk cohorts for targeted screening should be a priority. 
